Cold Supply Chain Pharmaceuticals: How to Safeguard Sensitive Medicines in 2025?
How to Safeguard Sensitive Medicines in 2025? Updated on November 13 2025. Cold supply chain pharmaceuticals refer to the systems and processes that keep vaccines, biologics and gene therapies within strict temperature ranges during storage, transport and lastmile delivery. In 2025 this sector is booming – analysts estimate the global cold chain logistics market will grow from US$436 billion in 2025 to over US$1.3 trillion by 2034. Maintaining temperature integrity is not only about compliance but about saving lives and avoiding costly product losses. This guide helps you navigate the evolving landscape with clear strategies, realworld examples and uptodate insights. What cold supply chain pharmaceuticals are and why they matter, including temperature ranges and critical components. How technologies like AI, IoT and blockchain enhance cold chain visibility and efficiency, and which innovations provide the greatest value. Best practices for compliance and safety, from using pharmaceuticalgrade refrigerators to installing data loggers. Trends shaping 2025 and beyond, such as rapid market expansion, biologics growth, sustainable packaging and...